EMA Wants More Staff For Continuing Pandemic Workload
Agency Expects 11 COVID-19-Related Product Applications This Year
The more products the European Medicines Agency approves, the more post-authorization applications it receives, leading to an ever-growing spiral in its workload. This, together with the increase in COVID-19-related tasks, new responsibilities in clinical trials and other areas, and a decline in staff numbers over the years, is posing some real resource issues at the agency.
